Biomechanical strain causes maladaptive gene regulation, contributing to alport glomerular disease

Daniel T. Meehan, Duane Delimont, Linda Cheung, Marisa L Zallocchi, Steven Claude Sansom, J. David Holzclaw, Velidi Rao, Dominic E Cosgrove

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Patients with Alport's syndrome develop a number of pro-inflammatory cytokine and matrix metalloproteinase (MMP) abnormalities that contribute to progressive renal failure. Changes in the composition and structure of the glomerular basement membranes likely alter the biomechanics of cell adhesion and signaling in these patients. To test if enhanced strain on the capillary tuft due to these structural changes contributes to altered gene regulation, we subjected cultured podocytes to cyclic biomechanical strain. There was robust induction of interleukin (IL)-6, along with MMP-3,-9,-10, and-14, but not MMP-2 or-12 by increased strain. Neutralizing antibodies against IL-6 attenuated the strain-mediated induction of MMP-3 and-10. Alport mice treated with a general inhibitor of nitric oxide synthase (L-NAME) developed significant hypertension and increased IL-6 and MMP-3 and-10 in their glomeruli relative to those of normotensive Alport mice. These hypertensive Alport mice also had elevated proteinuria along with more advanced histological and ultrastructural glomerular basement membrane damage. We suggest that MMP and cytokine dysregulation may constitute a maladaptive response to biomechanical strain in the podocytes of Alport patients, thus contributing to glomerular disease initiation and progression.

Original languageEnglish (US)
Pages (from-to)968-976
Number of pages9
JournalKidney International
Volume76
Issue number9
DOIs
StatePublished - Nov 1 2009

Fingerprint

Matrix Metalloproteinase 3
Matrix Metalloproteinase 10
Interleukin-6
Podocytes
Glomerular Basement Membrane
Matrix Metalloproteinases
Hereditary Nephritis
Cytokines
Genes
Matrix Metalloproteinase 2
NG-Nitroarginine Methyl Ester
Matrix Metalloproteinase 9
Neutralizing Antibodies
Proteinuria
Biomechanical Phenomena
Cell Adhesion
Nitric Oxide Synthase
Renal Insufficiency
Disease Progression
Hypertension

Keywords

  • Alport syndrome
  • Biomechanical strain
  • Podocyte adhesion

ASJC Scopus subject areas

  • Nephrology

Cite this

Biomechanical strain causes maladaptive gene regulation, contributing to alport glomerular disease. / Meehan, Daniel T.; Delimont, Duane; Cheung, Linda; Zallocchi, Marisa L; Sansom, Steven Claude; Holzclaw, J. David; Rao, Velidi; Cosgrove, Dominic E.

In: Kidney International, Vol. 76, No. 9, 01.11.2009, p. 968-976.

Research output: Contribution to journalArticle

Meehan, Daniel T. ; Delimont, Duane ; Cheung, Linda ; Zallocchi, Marisa L ; Sansom, Steven Claude ; Holzclaw, J. David ; Rao, Velidi ; Cosgrove, Dominic E. / Biomechanical strain causes maladaptive gene regulation, contributing to alport glomerular disease. In: Kidney International. 2009 ; Vol. 76, No. 9. pp. 968-976.
@article{3848bc7c57ca449e93916ceb434f5881,
title = "Biomechanical strain causes maladaptive gene regulation, contributing to alport glomerular disease",
abstract = "Patients with Alport's syndrome develop a number of pro-inflammatory cytokine and matrix metalloproteinase (MMP) abnormalities that contribute to progressive renal failure. Changes in the composition and structure of the glomerular basement membranes likely alter the biomechanics of cell adhesion and signaling in these patients. To test if enhanced strain on the capillary tuft due to these structural changes contributes to altered gene regulation, we subjected cultured podocytes to cyclic biomechanical strain. There was robust induction of interleukin (IL)-6, along with MMP-3,-9,-10, and-14, but not MMP-2 or-12 by increased strain. Neutralizing antibodies against IL-6 attenuated the strain-mediated induction of MMP-3 and-10. Alport mice treated with a general inhibitor of nitric oxide synthase (L-NAME) developed significant hypertension and increased IL-6 and MMP-3 and-10 in their glomeruli relative to those of normotensive Alport mice. These hypertensive Alport mice also had elevated proteinuria along with more advanced histological and ultrastructural glomerular basement membrane damage. We suggest that MMP and cytokine dysregulation may constitute a maladaptive response to biomechanical strain in the podocytes of Alport patients, thus contributing to glomerular disease initiation and progression.",
keywords = "Alport syndrome, Biomechanical strain, Podocyte adhesion",
author = "Meehan, {Daniel T.} and Duane Delimont and Linda Cheung and Zallocchi, {Marisa L} and Sansom, {Steven Claude} and Holzclaw, {J. David} and Velidi Rao and Cosgrove, {Dominic E}",
year = "2009",
month = "11",
day = "1",
doi = "10.1038/ki.2009.324",
language = "English (US)",
volume = "76",
pages = "968--976",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Biomechanical strain causes maladaptive gene regulation, contributing to alport glomerular disease

AU - Meehan, Daniel T.

AU - Delimont, Duane

AU - Cheung, Linda

AU - Zallocchi, Marisa L

AU - Sansom, Steven Claude

AU - Holzclaw, J. David

AU - Rao, Velidi

AU - Cosgrove, Dominic E

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Patients with Alport's syndrome develop a number of pro-inflammatory cytokine and matrix metalloproteinase (MMP) abnormalities that contribute to progressive renal failure. Changes in the composition and structure of the glomerular basement membranes likely alter the biomechanics of cell adhesion and signaling in these patients. To test if enhanced strain on the capillary tuft due to these structural changes contributes to altered gene regulation, we subjected cultured podocytes to cyclic biomechanical strain. There was robust induction of interleukin (IL)-6, along with MMP-3,-9,-10, and-14, but not MMP-2 or-12 by increased strain. Neutralizing antibodies against IL-6 attenuated the strain-mediated induction of MMP-3 and-10. Alport mice treated with a general inhibitor of nitric oxide synthase (L-NAME) developed significant hypertension and increased IL-6 and MMP-3 and-10 in their glomeruli relative to those of normotensive Alport mice. These hypertensive Alport mice also had elevated proteinuria along with more advanced histological and ultrastructural glomerular basement membrane damage. We suggest that MMP and cytokine dysregulation may constitute a maladaptive response to biomechanical strain in the podocytes of Alport patients, thus contributing to glomerular disease initiation and progression.

AB - Patients with Alport's syndrome develop a number of pro-inflammatory cytokine and matrix metalloproteinase (MMP) abnormalities that contribute to progressive renal failure. Changes in the composition and structure of the glomerular basement membranes likely alter the biomechanics of cell adhesion and signaling in these patients. To test if enhanced strain on the capillary tuft due to these structural changes contributes to altered gene regulation, we subjected cultured podocytes to cyclic biomechanical strain. There was robust induction of interleukin (IL)-6, along with MMP-3,-9,-10, and-14, but not MMP-2 or-12 by increased strain. Neutralizing antibodies against IL-6 attenuated the strain-mediated induction of MMP-3 and-10. Alport mice treated with a general inhibitor of nitric oxide synthase (L-NAME) developed significant hypertension and increased IL-6 and MMP-3 and-10 in their glomeruli relative to those of normotensive Alport mice. These hypertensive Alport mice also had elevated proteinuria along with more advanced histological and ultrastructural glomerular basement membrane damage. We suggest that MMP and cytokine dysregulation may constitute a maladaptive response to biomechanical strain in the podocytes of Alport patients, thus contributing to glomerular disease initiation and progression.

KW - Alport syndrome

KW - Biomechanical strain

KW - Podocyte adhesion

UR - http://www.scopus.com/inward/record.url?scp=70350074361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350074361&partnerID=8YFLogxK

U2 - 10.1038/ki.2009.324

DO - 10.1038/ki.2009.324

M3 - Article

C2 - 19710627

AN - SCOPUS:70350074361

VL - 76

SP - 968

EP - 976

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 9

ER -